{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:50:23Z","timestamp":1792086623320,"version":"4.4.0"},"reference-count":262,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-026-00744-4","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:32:43Z","timestamp":1792085563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dengue virus infection"],"prefix":"10.1038","volume":"12","author":[{"given":"Yaw Shin","family":"Ooi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7797-5365","authenticated-orcid":false,"given":"Jonathan","family":"Cattrall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9319-5908","authenticated-orcid":false,"given":"Shirin","family":"Kalimuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue Tao","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3066-5938","authenticated-orcid":false,"given":"Eduardo","family":"Lopez-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8368-7682","authenticated-orcid":false,"given":"Stephen J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0520-1544","authenticated-orcid":false,"given":"Eng Eong","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"744_CR1","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00244-24","volume":"38","author":"S Kalimuddin","year":"2025","unstructured":"Kalimuddin, S., Chia, P. Y., Low, J. G. & Ooi, E. E. Dengue and severe dengue. Clin. Microbiol. Rev. 38, e00244-24 https:\/\/doi.org\/10.1128\/cmr.00244-24 (2025).","journal-title":"Clin. Microbiol. Rev."},{"key":"744_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.tim.2013.12.011","volume":"22","author":"JP Messina","year":"2014","unstructured":"Messina, J. P. et al. Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol. 22, 138\u2013146 https:\/\/doi.org\/10.1016\/j.tim.2013.12.011 (2014).","journal-title":"Trends Microbiol."},{"key":"744_CR3","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/S0140-6736(20)31375-1","volume":"395","author":"A Wilder-Smith","year":"2020","unstructured":"Wilder-Smith, A. et al. The Lancet Commission on dengue and other Aedes-transmitted viral diseases. Lancet 395, 1890\u20131891 https:\/\/doi.org\/10.1016\/S0140-6736(20)31375-1 (2020).","journal-title":"Lancet"},{"key":"744_CR4","doi-asserted-by":"publisher","first-page":"e0008603","DOI":"10.1371\/journal.pntd.0008603","volume":"14","author":"P Dussart","year":"2020","unstructured":"Dussart, P. et al. Comparison of dengue case classification schemes and evaluation of biological changes in different dengue clinical patterns in a longitudinal follow-up of hospitalized children in Cambodia. PLoS Negl. Trop. Dis. 14, e0008603 https:\/\/doi.org\/10.1371\/journal.pntd.0008603 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-106","volume":"11","author":"J Barniol","year":"2011","unstructured":"Barniol, J. et al. Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries. BMC Infect. Dis. 11, 106 https:\/\/doi.org\/10.1186\/1471-2334-11-106 (2011).","journal-title":"BMC Infect. Dis."},{"key":"744_CR6","doi-asserted-by":"publisher","first-page":"e0012846","DOI":"10.1371\/journal.pntd.0012846","volume":"19","author":"C-H Yang","year":"2025","unstructured":"Yang, C.-H. et al. Prognostic factors in severe dengue patients: a multi-center retrospective cohort study. PLoS Negl. Trop. Dis. 19, e0012846 https:\/\/doi.org\/10.1371\/journal.pntd.0012846 (2025).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR7","doi-asserted-by":"publisher","first-page":"e0014395","DOI":"10.1371\/journal.pntd.0014395","volume":"20","author":"HC Turner","year":"2026","unstructured":"Turner, H. C. et al. The cost-effectiveness of Wolbachia-based biocontrol interventions for dengue: a scoping review of the available evidence. PLoS Negl. Trop. Dis. 20, e0014395 https:\/\/doi.org\/10.1371\/journal.pntd.0014395 (2026).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR8","doi-asserted-by":"publisher","first-page":"eaax4144","DOI":"10.1126\/scitranslmed.aax4144","volume":"12","author":"L Cattarino","year":"2020","unstructured":"Cattarino, L., Rodriguez-Barraquer, I., Imai, N., Cummings, D. A. T. & Ferguson, N. M. Mapping global variation in dengue transmission intensity. Sci. Transl. Med. 12, eaax4144 https:\/\/doi.org\/10.1126\/scitranslmed.aax4144 (2020).","journal-title":"Sci. Transl. Med."},{"key":"744_CR9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504\u2013507 https:\/\/doi.org\/10.1038\/nature12060 (2013).","journal-title":"Nature"},{"key":"744_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20069","volume":"9","author":"O De Santis","year":"2023","unstructured":"De Santis, O., Bouscaren, N. & Flahault, A. Asymptomatic dengue infection rate: a systematic literature review. Heliyon 9, e20069 https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20069 (2023).","journal-title":"Heliyon"},{"key":"744_CR11","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"A Ferrari","year":"2024","unstructured":"Ferrari, A. et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2133\u20132161 https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8 (2024).","journal-title":"Lancet"},{"key":"744_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.107940","volume":"158","author":"N Haider","year":"2025","unstructured":"Haider, N. et al. Global dengue epidemic worsens with record 14 million cases and 9000 deaths reported in 2024. Int. J. Infect. Dis. 158, 107940 https:\/\/doi.org\/10.1016\/j.ijid.2025.107940 (2025).","journal-title":"Int. J. Infect. Dis."},{"key":"744_CR13","doi-asserted-by":"publisher","first-page":"e0010586","DOI":"10.1371\/journal.pntd.0010586","volume":"16","author":"N Srisawat","year":"2022","unstructured":"Srisawat, N. et al. World Dengue Day: a call for action. PLoS Negl. Trop. Dis. 16, e0010586 https:\/\/doi.org\/10.1371\/journal.pntd.0010586 (2022).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4269\/ajtmh.23-0542","volume":"111","author":"N Gupta","year":"2024","unstructured":"Gupta, N., Boodman, C., Jouego, C. G. & Van Den Broucke, S. Duration of fever in patients with dengue: a systematic review and meta-analysis. Am. J. Trop. Med. Hyg. 111, 5\u201310 https:\/\/doi.org\/10.4269\/ajtmh.23-0542 (2024).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"744_CR15","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S1473-3099(16)00146-8","volume":"16","author":"DS Shepard","year":"2016","unstructured":"Shepard, D. S., Undurraga, E. A., Halasa, Y. A. & Stanaway, J. D. The global economic burden of dengue: a systematic analysis. Lancet Infect. Dis. 16, 935\u2013941 https:\/\/doi.org\/10.1016\/S1473-3099(16)00146-8 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"744_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-31273-x","volume":"16","author":"RO Okpanachi","year":"2025","unstructured":"Okpanachi, R. O. et al. Dengue virus infection amongst malaria and typhoid fever suspected acute febrile patients in the Niger river basin of Nigeria. Sci. Rep. 16, 1699 https:\/\/doi.org\/10.1038\/s41598-025-31273-x (2025).","journal-title":"Sci. Rep."},{"key":"744_CR17","doi-asserted-by":"publisher","first-page":"e2324","DOI":"10.1371\/journal.pntd.0002324","volume":"7","author":"JA Crump","year":"2013","unstructured":"Crump, J. A. et al. Etiology of severe non-malaria febrile illness in Northern Tanzania: a prospective cohort study. PLoS Negl. Trop. Dis. 7, e2324 https:\/\/doi.org\/10.1371\/journal.pntd.0002324 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR18","doi-asserted-by":"publisher","first-page":"e1012771","DOI":"10.1371\/journal.pcbi.1012771","volume":"21","author":"OJ Brady","year":"2025","unstructured":"Brady, O. J. et al. Why the growth of arboviral diseases necessitates a new generation of global risk maps and future projections. PLoS Comput. Biol. 21, e1012771 https:\/\/doi.org\/10.1371\/journal.pcbi.1012771 (2025).","journal-title":"PLoS Comput. Biol."},{"key":"744_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58609-5","volume":"16","author":"A Lim","year":"2025","unstructured":"Lim, A. et al. The overlapping global distribution of dengue, chikungunya, Zika and yellow fever. Nat. Commun. 16, 3418 https:\/\/doi.org\/10.1038\/s41467-025-58609-5 (2025).","journal-title":"Nat. Commun."},{"key":"744_CR20","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1126\/science.aaj9384","volume":"355","author":"H Salje","year":"2017","unstructured":"Salje, H. et al. Dengue diversity across spatial and temporal scales: local structure and the effect of host population size. Science 355, 1302\u20131306 https:\/\/doi.org\/10.1126\/science.aaj9384 (2017).","journal-title":"Science"},{"key":"744_CR21","doi-asserted-by":"publisher","first-page":"e0011333","DOI":"10.1371\/journal.pntd.0011333","volume":"17","author":"O Man","year":"2023","unstructured":"Man, O. et al. Characterizing dengue transmission in rural areas: a systematic review. PLoS Negl. Trop. Dis. 17, e0011333 https:\/\/doi.org\/10.1371\/journal.pntd.0011333 (2023).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR22","doi-asserted-by":"publisher","unstructured":"Clarke, J. et al. OpenDengue: data from the OpenDengue database. Figshare https:\/\/doi.org\/10.6084\/m9.figshare.24259573 (2024).","DOI":"10.6084\/m9.figshare.24259573"},{"key":"744_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-024-03120-7","volume":"11","author":"J Clarke","year":"2024","unstructured":"Clarke, J. et al. A global dataset of publicly available dengue case count data. Sci. Data 11, 296 https:\/\/doi.org\/10.1038\/s41597-024-03120-7 (2024).","journal-title":"Sci. Data"},{"key":"744_CR24","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3201\/eid1708.101515","volume":"17","author":"A Amarasinghe","year":"2011","unstructured":"Amarasinghe, A., Kuritsk, J. N., Letson, G. W. & Margolis, H. S. Dengue virus infection in Africa. Emerg. Infect. Dis. 17, 1349\u20131354 https:\/\/doi.org\/10.3201\/eid1708.101515 (2011).","journal-title":"Emerg. Infect. Dis."},{"key":"744_CR25","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41564-019-0376-y","volume":"4","author":"MUG Kraemer","year":"2019","unstructured":"Kraemer, M. U. G. et al. Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus. Nat. Microbiol. 4, 854\u2013863 https:\/\/doi.org\/10.1038\/s41564-019-0376-y (2019).","journal-title":"Nat. Microbiol."},{"key":"744_CR26","doi-asserted-by":"publisher","DOI":"10.1017\/S095026882610123X","volume":"154","author":"MB Brugger","year":"2026","unstructured":"Brugger, M. B., Valero, M. A. & Morales-Su\u00e1rez-Varela, M. Autochthonous transmission of dengue in Europe, with special attention to the Spanish context. Epidemiol. Infect. 154, e38 https:\/\/doi.org\/10.1017\/S095026882610123X (2026).","journal-title":"Epidemiol. Infect."},{"key":"744_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101231","volume":"51","author":"P Cattaneo","year":"2025","unstructured":"Cattaneo, P. et al. Transmission of autochthonous Aedes-borne arboviruses and related public health challenges in Europe 2007\u20132023: a systematic review and secondary analysis. Lancet Reg. Health Eur. 51, 101231 https:\/\/doi.org\/10.1016\/j.lanepe.2025.101231 (2025).","journal-title":"Lancet Reg. Health Eur."},{"key":"744_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2149\/tmh.2011-S05","volume":"39","author":"DJ Gubler","year":"2011","unstructured":"Gubler, D. J. Dengue, urbanization and globalization: the unholy trinity of the 21st century. Trop. Med. Health 39, 3\u201311 https:\/\/doi.org\/10.2149\/tmh.2011-S05 (2011).","journal-title":"Trop. Med. Health"},{"key":"744_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43954-0","volume":"14","author":"R Gibb","year":"2023","unstructured":"Gibb, R. et al. Interactions between climate change, urban infrastructure and mobility are driving dengue emergence in Vietnam. Nat. Commun. 14, 8179 https:\/\/doi.org\/10.1038\/s41467-023-43954-0 (2023).","journal-title":"Nat. Commun."},{"key":"744_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48465-0","volume":"15","author":"V Harish","year":"2024","unstructured":"Harish, V. et al. Human movement and environmental barriers shape the emergence of dengue. Nat. Commun. 15, 4205 https:\/\/doi.org\/10.1038\/s41467-024-48465-0 (2024).","journal-title":"Nat. Commun."},{"key":"744_CR31","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/s41564-019-0476-8","volume":"4","author":"JP Messina","year":"2019","unstructured":"Messina, J. P. et al. The current and future global distribution and population at risk of dengue. Nat. Microbiol. 4, 1508\u20131515 https:\/\/doi.org\/10.1038\/s41564-019-0476-8 (2019).","journal-title":"Nat. Microbiol."},{"key":"744_CR32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.envres.2019.02.026","volume":"172","author":"J Liu-Helmersson","year":"2019","unstructured":"Liu-Helmersson, J., Rockl\u00f6v, J., Sewe, M. & Br\u00e4nnstr\u00f6m, \u00c5. Climate change may enable Aedes aegypti infestation in major European cities by 2100. Environ. Res. 172, 693\u2013699 https:\/\/doi.org\/10.1016\/j.envres.2019.02.026 (2019).","journal-title":"Environ. Res."},{"key":"744_CR33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2512350122","volume":"122","author":"ML Childs","year":"2025","unstructured":"Childs, M. L., Lyberger, K., Harris, M. J., Burke, M. & Mordecai, E. A. Climate warming is expanding dengue burden in the Americas and Asia. Proc. Natl Acad. Sci. USA 122, e2512350122 https:\/\/doi.org\/10.1073\/pnas.2512350122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"744_CR34","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1016\/S2542-5196(21)00132-7","volume":"5","author":"FJ Colon-Gonzalez","year":"2021","unstructured":"Col\u00f3n-Gonz\u00e1lez, F. J. et al. Projecting the risk of mosquito-borne diseases in a warmer and more populated world: a multi-model, multi-scenario intercomparison modelling study. Lancet Planet. Health 5, e404\u2013e414 https:\/\/doi.org\/10.1016\/S2542-5196(21)00132-7 (2021).","journal-title":"Lancet Planet. Health"},{"key":"744_CR35","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.tim.2025.05.007","volume":"33","author":"ANX Choi","year":"2025","unstructured":"Choi, A. N. X., Gubler, D. J. & Ooi, E. E. Genetics of dengue epidemics. Trends Microbiol. 33, 1099\u20131109\u00a0https:\/\/doi.org\/10.1016\/j.tim.2025.05.007 (2025).","journal-title":"Trends Microbiol."},{"key":"744_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105134","volume":"104","author":"A Vicco","year":"2024","unstructured":"Vicco, A. et al. A scoping literature review of global dengue age-stratified seroprevalence data: estimating dengue force of infection in endemic countries. eBioMedicine 104, 105134 https:\/\/doi.org\/10.1016\/j.ebiom.2024.105134 (2024).","journal-title":"eBioMedicine"},{"key":"744_CR37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2115790119","volume":"119","author":"AT Huang","year":"2022","unstructured":"Huang, A. T. et al. Assessing the role of multiple mechanisms increasing the age of dengue cases in Thailand. Proc. Natl Acad. Sci. USA 119, e2115790119 https:\/\/doi.org\/10.1073\/pnas.2115790119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"744_CR38","doi-asserted-by":"publisher","first-page":"e0004262","DOI":"10.1371\/journal.pntd.0004262","volume":"9","author":"H Clapham","year":"2015","unstructured":"Clapham, H. et al. Epidemiology of infant dengue cases illuminates serotype-specificity in the interaction between immunity and disease, and changes in transmission dynamics. PLoS Negl. Trop. Dis. 9, e0004262 https:\/\/doi.org\/10.1371\/journal.pntd.0004262 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR39","doi-asserted-by":"publisher","first-page":"e0273071","DOI":"10.1371\/journal.pone.0273071","volume":"17","author":"WY Ng","year":"2022","unstructured":"Ng, W. Y. et al. A double whammy: the association between comorbidities and severe dengue among adult patients\u2014a matched case-control study. PLoS ONE 17, e0273071 https:\/\/doi.org\/10.1371\/journal.pone.0273071 (2022).","journal-title":"PLoS ONE"},{"key":"744_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.18502\/jad.v18i3.18579","volume":"18","author":"M Akter","year":"2024","unstructured":"Akter, M., Araf, Y., Akter, S. & Hossain, M. G. Dengue in Bangladesh: a gendered perspective on infection and fatality rates amidst global epidemiological trends. J. Arthropod-Borne Dis. 18, 281\u2013284 https:\/\/doi.org\/10.18502\/jad.v18i3.18579 (2024).","journal-title":"J. Arthropod-Borne Dis."},{"key":"744_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1179\/2047773214Y.0000000168","volume":"109","author":"K Mulligan","year":"2015","unstructured":"Mulligan, K., Dixon, J., Sinn, C.-L. J. & Elliott, S. J. Is dengue a disease of poverty? A systematic review. Pathog. Glob. Health 109, 10\u201318 https:\/\/doi.org\/10.1179\/2047773214Y.0000000168 (2015).","journal-title":"Pathog. Glob. Health"},{"key":"744_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1019238","volume":"2020","author":"J Abd-Jamil","year":"2020","unstructured":"Abd-Jamil, J. et al. Possible factors influencing the seroprevalence of dengue among residents of the forest fringe areas of Peninsular Malaysia. J. Trop. Med. 2020, 1019238 https:\/\/doi.org\/10.1155\/2020\/1019238 (2020).","journal-title":"J. Trop. Med."},{"key":"744_CR43","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.humpath.2014.01.022","volume":"45","author":"KS Aye","year":"2014","unstructured":"Aye, K. S. et al. Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. Hum. Pathol. 45, 1221\u20131233 https:\/\/doi.org\/10.1016\/j.humpath.2014.01.022 (2014).","journal-title":"Hum. Pathol."},{"key":"744_CR44","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41586-025-09500-2","volume":"646","author":"E Mittler","year":"2025","unstructured":"Mittler, E. et al. LRP8 is a receptor for tick-borne encephalitis virus. Nature 646, 945\u2013952 https:\/\/doi.org\/10.1038\/s41586-025-09500-2 (2025).","journal-title":"Nature"},{"key":"744_CR45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2525771122","volume":"122","author":"P Li","year":"2025","unstructured":"Li, P. et al. LRP8 is an entry receptor for tick-borne encephalitis viruses. Proc. Natl Acad. Sci. USA 122, e2525771122 https:\/\/doi.org\/10.1073\/pnas.2525771122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"744_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41586-025-09689-2","volume":"649","author":"Z Chong","year":"2026","unstructured":"Chong, Z. et al. Multiple LDLR family members act as entry receptors for yellow fever virus. Nature 649, 173\u2013182 https:\/\/doi.org\/10.1038\/s41586-025-09689-2 (2026).","journal-title":"Nature"},{"key":"744_CR47","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41564-026-02278-7","volume":"11","author":"M Mei","year":"2026","unstructured":"Mei, M. et al. LRP8 is a functional receptor for yellow fever virus. Nat. Microbiol. 11, 1022\u20131036 https:\/\/doi.org\/10.1038\/s41564-026-02278-7 (2026).","journal-title":"Nat. Microbiol."},{"key":"744_CR48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/femsre\/fuu004","volume":"39","author":"C Cruz-Oliveira","year":"2015","unstructured":"Cruz-Oliveira, C. et al. Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol. Rev. 39, 155\u2013170 https:\/\/doi.org\/10.1093\/femsre\/fuu004 (2015).","journal-title":"FEMS Microbiol. Rev."},{"key":"744_CR49","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nm0897-866","volume":"3","author":"Y Chen","year":"1997","unstructured":"Chen, Y. et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3, 866\u2013871 https:\/\/doi.org\/10.1038\/nm0897-866 (1997).","journal-title":"Nat. Med."},{"key":"744_CR50","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1084\/jem.20021840","volume":"197","author":"B Tassaneetrithep","year":"2003","unstructured":"Tassaneetrithep, B. et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197, 823\u2013829 https:\/\/doi.org\/10.1084\/jem.20021840 (2003).","journal-title":"J. Exp. Med."},{"key":"744_CR51","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/sj.embor.embor866","volume":"4","author":"E Navarro-Sanchez","year":"2003","unstructured":"Navarro-Sanchez, E. et al. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep. 4, 723\u2013728 https:\/\/doi.org\/10.1038\/sj.embor.embor866 (2003).","journal-title":"EMBO Rep."},{"key":"744_CR52","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00705-003-0263-x","volume":"149","author":"S Jindadamrongwech","year":"2004","unstructured":"Jindadamrongwech, S., Thepparit, C. & Smith, D. R. Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch. Virol. 149, 915\u2013927 https:\/\/doi.org\/10.1007\/s00705-003-0263-x (2004).","journal-title":"Arch. Virol."},{"key":"744_CR53","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1128\/JVI.79.8.4557-4567.2005","volume":"79","author":"J Reyes-Del Valle","year":"2005","unstructured":"Reyes-del Valle, J., Ch\u00e1vez-Salinas, S., Medina, F. & del Angel, R. M. Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J. Virol. 79, 4557\u20134567 https:\/\/doi.org\/10.1128\/JVI.79.8.4557-4567.2005 (2005).","journal-title":"J. Virol."},{"key":"744_CR54","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.chom.2012.08.009","volume":"12","author":"L Meertens","year":"2012","unstructured":"Meertens, L. et al. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12, 544\u2013557 https:\/\/doi.org\/10.1016\/j.chom.2012.08.009 (2012).","journal-title":"Cell Host Microbe"},{"key":"744_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adh3067","volume":"15","author":"EE Ooi","year":"2023","unstructured":"Ooi, E. E. & Kalimuddin, S. Insights into dengue immunity from vaccine trials. Sci. Transl. Med. 15, eadh3067 https:\/\/doi.org\/10.1126\/scitranslmed.adh3067 (2023).","journal-title":"Sci. Transl. Med."},{"key":"744_CR56","doi-asserted-by":"publisher","first-page":"e1012683","DOI":"10.1371\/journal.ppat.1012683","volume":"20","author":"C Gebo","year":"2024","unstructured":"Gebo, C. et al. B cell receptor dependent enhancement of dengue virus infection. PLoS Pathog. 20, e1012683 https:\/\/doi.org\/10.1371\/journal.ppat.1012683 (2024).","journal-title":"PLoS Pathog."},{"key":"744_CR57","doi-asserted-by":"publisher","first-page":"E12363","DOI":"10.1073\/pnas.1813819115","volume":"115","author":"F Zanini","year":"2018","unstructured":"Zanini, F. et al. Virus-inclusive single-cell RNA sequencing reveals the molecular signature of progression to severe dengue. Proc. Natl Acad. Sci. USA 115, E12363\u2013E12369 https:\/\/doi.org\/10.1073\/pnas.1813819115 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"744_CR58","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1146\/annurev-biochem-060208-104626","volume":"79","author":"J Mercer","year":"2010","unstructured":"Mercer, J., Schelhaas, M. & Helenius, A. Virus entry by endocytosis. Annu. Rev. Biochem. 79, 803\u2013833 https:\/\/doi.org\/10.1146\/annurev-biochem-060208-104626 (2010).","journal-title":"Annu. Rev. Biochem."},{"key":"744_CR59","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1073\/pnas.1424098112","volume":"112","author":"BA Hackett","year":"2015","unstructured":"Hackett, B. A. et al. RNASEK is required for internalization of diverse acid-dependent viruses. Proc. Natl Acad. Sci. USA 112, 7797\u20137802 https:\/\/doi.org\/10.1073\/pnas.1424098112 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"744_CR60","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.celrep.2015.06.076","volume":"12","author":"JM Perreira","year":"2015","unstructured":"Perreira, J. M. et al. RNASEK is a V-ATPase-associated factor required for endocytosis and the replication of rhinovirus, influenza A virus, and dengue virus. Cell Rep. 12, 850\u2013863 https:\/\/doi.org\/10.1016\/j.celrep.2015.06.076 (2015).","journal-title":"Cell Rep."},{"key":"744_CR61","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1073\/pnas.1720032115","volume":"115","author":"BA Hackett","year":"2018","unstructured":"Hackett, B. A. & Cherry, S. Flavivirus internalization is regulated by a size-dependent endocytic pathway. Proc. Natl Acad. Sci. USA 115, 4246\u20134251 https:\/\/doi.org\/10.1073\/pnas.1720032115 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"744_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.coviro.2012.12.001","volume":"3","author":"TC Pierson","year":"2013","unstructured":"Pierson, T. C. & Kielian, M. Flaviviruses: braking the entering. Curr. Opin. Virol. 3, 3\u201312 https:\/\/doi.org\/10.1016\/j.coviro.2012.12.001 (2013).","journal-title":"Curr. Opin. Virol."},{"key":"744_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45910-9","volume":"9","author":"NJ Barrows","year":"2019","unstructured":"Barrows, N. J. et al. Dual roles for the ER membrane protein complex in flavivirus infection: viral entry and protein biogenesis. Sci. Rep. 9, 9711 https:\/\/doi.org\/10.1038\/s41598-019-45910-9 (2019).","journal-title":"Sci. Rep."},{"key":"744_CR64","doi-asserted-by":"publisher","first-page":"e1010717","DOI":"10.1371\/journal.ppat.1010717","volume":"18","author":"P Bagchi","year":"2022","unstructured":"Bagchi, P., Speckhart, K., Kennedy, A., Tai, A. W. & Tsai, B. A specific EMC subunit supports dengue virus infection by promoting virus membrane fusion essential for cytosolic genome delivery. PLoS Pathog. 18, e1010717 https:\/\/doi.org\/10.1371\/journal.ppat.1010717 (2022).","journal-title":"PLoS Pathog."},{"key":"744_CR65","doi-asserted-by":"publisher","first-page":"e00804","DOI":"10.1128\/mBio.00804-16","volume":"7","author":"LA Byk","year":"2016","unstructured":"Byk, L. A. et al. Dengue virus genome uncoating requires ubiquitination. mBio 7, e00804\u201316 https:\/\/doi.org\/10.1128\/mBio.00804-16 (2016).","journal-title":"mBio"},{"key":"744_CR66","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/s41564-019-0518-2","volume":"4","author":"YS Ooi","year":"2019","unstructured":"Ooi, Y. S. et al. An RNA-centric dissection of host complexes controlling flavivirus infection. Nat. Microbiol. 4, 2369\u20132382 https:\/\/doi.org\/10.1038\/s41564-019-0518-2 (2019).","journal-title":"Nat. Microbiol."},{"key":"744_CR67","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1128\/JVI.80.6.2976-2986.2006","volume":"80","author":"D Edgil","year":"2006","unstructured":"Edgil, D., Polacek, C. & Harris, E. Dengue virus utilizes a novel strategy for translation initiation when cap-dependent translation is inhibited. J. Virol. 80, 2976\u20132986 https:\/\/doi.org\/10.1128\/JVI.80.6.2976-2986.2006 (2006).","journal-title":"J. Virol."},{"key":"744_CR68","doi-asserted-by":"publisher","first-page":"e01766","DOI":"10.1128\/JVI.01766-17","volume":"92","author":"DW Reid","year":"2018","unstructured":"Reid, D. W. et al. Dengue virus selectively annexes endoplasmic reticulum-associated translation machinery as a strategy for co-opting host cell protein synthesis. J. Virol. 92, e01766\u201317 https:\/\/doi.org\/10.1128\/JVI.01766-17 (2018).","journal-title":"J. Virol."},{"key":"744_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116642","volume":"44","author":"M Verhaegen","year":"2025","unstructured":"Verhaegen, M. et al. Sec61 translocon inhibitor flavitransin blocks selectively dengue virus polyprotein insertion in the ER with pan-orthoflavivirus antiviral potency. Cell Rep. 44, 116642 https:\/\/doi.org\/10.1016\/j.celrep.2025.116642 (2025).","journal-title":"Cell Rep."},{"key":"744_CR70","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nature18631","volume":"535","author":"CD Marceau","year":"2016","unstructured":"Marceau, C. D. et al. Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens. Nature 535, 159\u2013163 https:\/\/doi.org\/10.1038\/nature18631 (2016).","journal-title":"Nature"},{"key":"744_CR71","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nature18625","volume":"535","author":"R Zhang","year":"2016","unstructured":"Zhang, R. et al. A CRISPR screen defines a signal peptide processing pathway required by flaviviruses. Nature 535, 164\u2013168 https:\/\/doi.org\/10.1038\/nature18625 (2016).","journal-title":"Nature"},{"key":"744_CR72","doi-asserted-by":"publisher","first-page":"e48469","DOI":"10.7554\/eLife.48469","volume":"8","author":"AM Ngo","year":"2019","unstructured":"Ngo, A. M. et al. The ER membrane protein complex is required to ensure correct topology and stable expression of flavivirus polyproteins. eLife 8, e48469 https:\/\/doi.org\/10.7554\/eLife.48469 (2019).","journal-title":"eLife"},{"key":"744_CR73","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/v17020287","volume":"17","author":"HM Schmidt","year":"2025","unstructured":"Schmidt, H. M. & Horner, S. M. Towards a universal translator: decoding the PTMs that regulate orthoflavivirus infection. Viruses 17, 287 https:\/\/doi.org\/10.3390\/v17020287 (2025).","journal-title":"Viruses"},{"key":"744_CR74","doi-asserted-by":"publisher","first-page":"e01962","DOI":"10.1128\/jvi.01962-21","volume":"96","author":"A Brugier","year":"2022","unstructured":"Brugier, A. et al. RACK1 associates with RNA-binding proteins vigilin and SERBP1 to facilitate dengue virus replication. J. Virol. 96, e01962-21 https:\/\/doi.org\/10.1128\/jvi.01962-21 (2022).","journal-title":"J. Virol."},{"key":"744_CR75","doi-asserted-by":"publisher","first-page":"e00596","DOI":"10.1128\/JVI.00596-21","volume":"95","author":"B Shue","year":"2021","unstructured":"Shue, B. et al. Genome-wide CRISPR screen identifies RACK1 as a critical host factor for flavivirus replication. J. Virol. 95, e00596-21 https:\/\/doi.org\/10.1128\/JVI.00596-21 (2021).","journal-title":"J. Virol."},{"key":"744_CR76","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1743-422X-4-91","volume":"4","author":"I Umareddy","year":"2007","unstructured":"Umareddy, I. et al. Dengue virus serotype infection specifies the activation of the unfolded protein response. Virol. J. 4, 91 https:\/\/doi.org\/10.1186\/1743-422X-4-91 (2007).","journal-title":"Virol. J."},{"key":"744_CR77","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.virol.2010.10.010","volume":"409","author":"P Klomporn","year":"2011","unstructured":"Klomporn, P., Panyasrivanit, M., Wikan, N. & Smith, D. R. Dengue infection of monocytic cells activates ER stress pathways, but apoptosis is induced through both extrinsic and intrinsic pathways. Virology 409, 189\u2013197 https:\/\/doi.org\/10.1016\/j.virol.2010.10.010(2011).","journal-title":"Virology"},{"key":"744_CR78","doi-asserted-by":"publisher","first-page":"14226","DOI":"10.1074\/jbc.M111.222703","volume":"286","author":"J Pena","year":"2011","unstructured":"Pe\u00f1a, J. & Harris, E. Dengue virus modulates the unfolded protein response in a time-dependent manner. J. Biol. Chem. 286, 14226\u201314236 https:\/\/doi.org\/10.1074\/jbc.M111.222703 (2011).","journal-title":"J. Biol. Chem."},{"key":"744_CR79","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02234-20","volume":"95","author":"K Tabata","year":"2021","unstructured":"Tabata, K. et al. Endoplasmic reticulum-associated degradation controls virus protein homeostasis, which is required for flavivirus propagation. J. Virol. 95, e0223420 https:\/\/doi.org\/10.1128\/JVI.02234-20 (2021).","journal-title":"J. Virol."},{"key":"744_CR80","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.cell.2015.10.046","volume":"163","author":"S Taguwa","year":"2015","unstructured":"Taguwa, S. et al. Defining Hsp70 subnetworks in dengue virus replication reveals key vulnerability in flavivirus infection. Cell 163, 1108\u20131123 https:\/\/doi.org\/10.1016\/j.cell.2015.10.046 (2015).","journal-title":"Cell"},{"key":"744_CR81","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41564-019-0586-3","volume":"4","author":"CJ Neufeldt","year":"2019","unstructured":"Neufeldt, C. J. et al. ER-shaping atlastin proteins act as central hubs to promote flavivirus replication and virion assembly. Nat. Microbiol. 4, 2416\u20132429 https:\/\/doi.org\/10.1038\/s41564-019-0586-3 (2019).","journal-title":"Nat. Microbiol."},{"key":"744_CR82","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3390\/v13102092","volume":"13","author":"C Mazeaud","year":"2021","unstructured":"Mazeaud, C. et al. The biogenesis of dengue virus replication organelles requires the ATPase activity of valosin-containing protein. Viruses 13, 2092 https:\/\/doi.org\/10.3390\/v13102092 (2021).","journal-title":"Viruses"},{"key":"744_CR83","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.celrep.2017.10.055","volume":"21","author":"TE Aktepe","year":"2017","unstructured":"Aktepe, T. E., Liebscher, S., Prier, J. E., Simmons, C. P. & Mackenzie, J. M. The host protein reticulon 3.1A is utilized by flaviviruses to facilitate membrane remodelling. Cell Rep. 21, 1639\u20131654 https:\/\/doi.org\/10.1016\/j.celrep.2017.10.055 (2017).","journal-title":"Cell Rep."},{"key":"744_CR84","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cell.2020.12.005","volume":"184","author":"H-H Hoffmann","year":"2021","unstructured":"Hoffmann, H.-H. et al. TMEM41B is a pan-flavivirus host factor. Cell 184, 133\u2013148.e20 https:\/\/doi.org\/10.1016\/j.cell.2020.12.005 (2021).","journal-title":"Cell"},{"key":"744_CR85","doi-asserted-by":"publisher","first-page":"e1010763","DOI":"10.1371\/journal.ppat.1010763","volume":"18","author":"M Yousefi","year":"2022","unstructured":"Yousefi, M. et al. TMEM41B and VMP1 modulate cellular lipid and energy metabolism for facilitating dengue virus infection. PLoS Pathog. 18, e1010763 https:\/\/doi.org\/10.1371\/journal.ppat.1010763 (2022).","journal-title":"PLoS Pathog."},{"key":"744_CR86","doi-asserted-by":"publisher","first-page":"5907","DOI":"10.1128\/JVI.03404-13","volume":"88","author":"L Chatel-Chaix","year":"2014","unstructured":"Chatel-Chaix, L. & Bartenschlager, R. Dengue virus- and hepatitis C virus-induced replication and assembly compartments: the enemy inside-caught in the web. J. Virol. 88, 5907\u20135911 https:\/\/doi.org\/10.1128\/JVI.03404-13 (2014).","journal-title":"J. Virol."},{"key":"744_CR87","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.chom.2010.10.006","volume":"8","author":"NS Heaton","year":"2010","unstructured":"Heaton, N. S. & Randall, G. Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe 8, 422\u2013432 https:\/\/doi.org\/10.1016\/j.chom.2010.10.006 (2010).","journal-title":"Cell Host Microbe"},{"key":"744_CR88","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.coviro.2012.02.011","volume":"2","author":"TC Pierson","year":"2012","unstructured":"Pierson, T. C. & Diamond, M. S. Degrees of maturity: the complex structure and biology of flaviviruses. Curr. Opin. Virol. 2, 168\u2013175 https:\/\/doi.org\/10.1016\/j.coviro.2012.02.011 (2012).","journal-title":"Curr. Opin. Virol."},{"key":"744_CR89","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.molmed.2024.03.006","volume":"30","author":"GN Malavige","year":"2024","unstructured":"Malavige, G. N. & Ogg, G. S. Molecular mechanisms in the pathogenesis of dengue infections. Trends Mol. Med. 30, 484\u2013498 https:\/\/doi.org\/10.1016\/j.molmed.2024.03.006 (2024).","journal-title":"Trends Mol. Med."},{"key":"744_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44559-9","volume":"13","author":"S Moallemi","year":"2023","unstructured":"Moallemi, S., Lloyd, A. R. & Rodrigo, C. Early biomarkers for prediction of severe manifestations of dengue fever: a systematic review and a meta-analysis. Sci. Rep. 13, 17485 https:\/\/doi.org\/10.1038\/s41598-023-44559-9 (2023).","journal-title":"Sci. Rep."},{"key":"744_CR91","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1038\/s41590-023-01654-3","volume":"24","author":"L Ghita","year":"2023","unstructured":"Ghita, L. et al. Global and cell type-specific immunological hallmarks of severe dengue progression identified via a systems immunology approach. Nat. Immunol. 24, 2150\u20132163 https:\/\/doi.org\/10.1038\/s41590-023-01654-3 (2023).","journal-title":"Nat. Immunol."},{"key":"744_CR92","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/infdis\/jix447","volume":"216","author":"H Tissera","year":"2017","unstructured":"Tissera, H. et al. Chymase level is a predictive biomarker of dengue hemorrhagic fever in pediatric and adult patients. J. Infect. Dis. 216, 1112\u20131121 https:\/\/doi.org\/10.1093\/infdis\/jix447 (2017).","journal-title":"J. Infect. Dis."},{"key":"744_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68844-z","volume":"10","author":"APS Rathore","year":"2020","unstructured":"Rathore, A. P. S. et al. Serum chymase levels correlate with severe dengue warning signs and clinical fluid accumulation in hospitalized pediatric patients. Sci. Rep. 10, 11856 https:\/\/doi.org\/10.1038\/s41598-020-68844-z (2020).","journal-title":"Sci. Rep."},{"key":"744_CR94","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/1743-422X-10-322","volume":"10","author":"WM Loke","year":"2013","unstructured":"Loke, W. M. et al. Augmentation of 5-lipoxygenase activity and expression during dengue serotype-2 infection. Virol. J. 10, 322 https:\/\/doi.org\/10.1186\/1743-422X-10-322 (2013).","journal-title":"Virol. J."},{"key":"744_CR95","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/infdis\/jiac383","volume":"226","author":"PY Chia","year":"2022","unstructured":"Chia, P. Y., Teo, A. & Yeo, T. W. Association of neutrophil mediators with dengue disease severity and cardiac impairment in adults. J. Infect. Dis. 226, 1974\u20131984 https:\/\/doi.org\/10.1093\/infdis\/jiac383 (2022).","journal-title":"J. Infect. Dis."},{"key":"744_CR96","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.tim.2024.04.011","volume":"32","author":"CLL Chua","year":"2024","unstructured":"Chua, C. L. L., Morales, R. F., Chia, P. Y., Yeo, T. W. & Teo, A. Neutrophils\u00a0\u2014 an understudied bystander in dengue? Trends Microbiol. 32, 1132\u20131142 https:\/\/doi.org\/10.1016\/j.tim.2024.04.011 (2024).","journal-title":"Trends Microbiol."},{"key":"744_CR97","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiaf035","author":"A Singh","year":"2025","unstructured":"Singh, A. et al. Early neutrophil responses are potential biomarkers to predict severe COVID-19 in adults. J. Leukoc. Biol. https:\/\/doi.org\/10.1093\/jleuko\/qiaf035 (2025).","journal-title":"J. Leukoc. Biol."},{"key":"744_CR98","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1016\/S0140-6736(15)60417-2","volume":"385","author":"S Yacoub","year":"2015","unstructured":"Yacoub, S., Wertheim, H., Simmons, C. P., Screaton, G. & Wills, B. Microvascular and endothelial function for risk prediction in dengue: an observational study. Lancet 385, S102 https:\/\/doi.org\/10.1016\/S0140-6736(15)60417-2 (2015).","journal-title":"Lancet"},{"key":"744_CR99","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/infdis\/jiw220","volume":"214","author":"S Yacoub","year":"2016","unstructured":"Yacoub, S. et al. Association of microvascular function and endothelial biomarkers with clinical outcome in dengue: an observational study. J. Infect. Dis. 214, 697\u2013706 https:\/\/doi.org\/10.1093\/infdis\/jiw220 (2016).","journal-title":"J. Infect. Dis."},{"key":"744_CR100","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/cid\/cix567","volume":"65","author":"S Yacoub","year":"2017","unstructured":"Yacoub, S. et al. Endothelial nitric oxide pathways in the pathophysiology of dengue: a prospective observational study. Clin. Infect. Dis. 65, 1453\u20131461 https:\/\/doi.org\/10.1093\/cid\/cix567 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"744_CR101","doi-asserted-by":"publisher","first-page":"RP92606","DOI":"10.7554\/eLife.92606","volume":"13","author":"NL Vuong","year":"2024","unstructured":"Vuong, N. L. et al. Dengue viremia kinetics and effects on platelet count and clinical outcomes: an analysis of 2340 patients from Vietnam. eLife 13, RP92606 https:\/\/doi.org\/10.7554\/eLife.92606 (2024).","journal-title":"eLife"},{"key":"744_CR102","doi-asserted-by":"publisher","first-page":"e00528","DOI":"10.1128\/msphere.00528-19","volume":"4","author":"CYY Chan","year":"2019","unstructured":"Chan, C. Y. Y. et al. Antibody-dependent dengue virus entry modulates cell intrinsic responses for enhanced infection. mSphere 4, e00528\u201319 https:\/\/doi.org\/10.1128\/msphere.00528-19 (2019).","journal-title":"mSphere"},{"key":"744_CR103","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2404159","volume":"13","author":"W Yuya","year":"2024","unstructured":"Yuya, W. et al. Progress and challenges in development of animal models for dengue virus infection. Emerg. Microbes Infect. 13, 2404159 https:\/\/doi.org\/10.1080\/22221751.2024.2404159 (2024).","journal-title":"Emerg. Microbes Infect."},{"key":"744_CR104","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S1473-3099(24)00100-2","volume":"24","author":"KE Lyke","year":"2024","unstructured":"Lyke, K. E. et al. Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial. Lancet Infect. Dis. 24, 896\u20131121 https:\/\/doi.org\/10.1016\/S1473-3099(24)00100-2 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"744_CR105","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.4269\/ajtmh.14-0132","volume":"91","author":"GE Snow","year":"2014","unstructured":"Snow, G. E., Haaland, B., Ooi, E. E. & Gubler, D. J. Review article: research on dengue during World War II revisited. Am. J. Trop. Med. Hyg. 91, 1203\u20131217 https:\/\/doi.org\/10.4269\/ajtmh.14-0132 (2014).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"744_CR106","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1086\/315215","volume":"181","author":"DW Vaughn","year":"2000","unstructured":"Vaughn, D. W. et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181, 2\u20131121 https:\/\/doi.org\/10.1086\/315215 (2000).","journal-title":"J. Infect. Dis."},{"key":"744_CR107","doi-asserted-by":"publisher","first-page":"e1121","DOI":"10.1371\/journal.pntd.0001309","volume":"5","author":"V Tricou","year":"2011","unstructured":"Tricou, V., Minh, N. N., Farrar, J., Tran, H. T. & Simmons, C. P. Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue. PLoS Negl. Trop. Dis. 5, e1121 https:\/\/doi.org\/10.1371\/journal.pntd.0001309 (2011).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR108","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01962-24","volume":"99","author":"CSC Hardy","year":"2025","unstructured":"Hardy, C. S. C., Wegman, A. D., Waldran, M. J., Chan, G. C. & Waickman, A. T. Conventional and antibody-enhanced DENV infection of human macrophages induces differential immunotranscriptomic profiles. J. Virol. 99, e1121 https:\/\/doi.org\/10.1128\/jvi.01962-24 (2025).","journal-title":"J. Virol."},{"key":"744_CR109","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1126\/science.aai8128","volume":"355","author":"TT Wang","year":"2017","unstructured":"Wang, T. T. et al. IgG antibodies to dengue enhanced for Fc\u03b3RIIIA binding determine disease severity. Science 355, 395\u2013398 https:\/\/doi.org\/10.1126\/science.aai8128 (2017).","journal-title":"Science"},{"key":"744_CR110","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1126\/science.abc7303","volume":"372","author":"S Bournazos","year":"2021","unstructured":"Bournazos, S. et al. Antibody fucosylation predicts disease severity in secondary dengue infection. Science 372, 1102\u20131105 https:\/\/doi.org\/10.1126\/science.abc7303 (2021).","journal-title":"Science"},{"key":"744_CR111","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41590-025-02363-9","volume":"27","author":"JA Cardona-Ospina","year":"2026","unstructured":"Cardona-Ospina, J. A. et al. IgA-driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humans. Nat. Immunol. 27, 126\u2013134 https:\/\/doi.org\/10.1038\/s41590-025-02363-9 (2026).","journal-title":"Nat. Immunol."},{"key":"744_CR112","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41591-024-02798-x","volume":"30","author":"C Aggarwal","year":"2024","unstructured":"Aggarwal, C. et al. Severe disease during both primary and secondary dengue virus infections in pediatric populations. Nat. Med. 30, 670\u2013674 https:\/\/doi.org\/10.1038\/s41591-024-02798-x (2024).","journal-title":"Nat. Med."},{"key":"744_CR113","doi-asserted-by":"publisher","first-page":"e1074","DOI":"10.1093\/cid\/ciaa1840","volume":"72","author":"NL Vuong","year":"2021","unstructured":"Vuong, N. L. et al. Higher plasma viremia in the febrile phase is associated with adverse dengue outcomes irrespective of infecting serotype or host immune status: an analysis of 5642 Vietnamese cases. Clin. Infect. Dis. 72, e1074\u2013e1083 https:\/\/doi.org\/10.1093\/cid\/ciaa1840 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"744_CR114","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0140-6736(20)30414-1","volume":"395","author":"S Biswal","year":"2020","unstructured":"Biswal, S. et al. Efficacy of a tetravalent dengue vaccine in healthy children aged 4\u201316 years: a randomised, placebo-controlled, phase 3 trial. Lancet 395, 1423\u20131433 https:\/\/doi.org\/10.1016\/S0140-6736(20)30414-1 (2020).","journal-title":"Lancet"},{"key":"744_CR115","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S1473-3099(24)00376-1","volume":"24","author":"ML Nogueira","year":"2024","unstructured":"Nogueira, M. L. et al. Efficacy and safety of Butantan-DV in participants aged 2\u201359 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil. Lancet Infect. Dis. 24, 1234\u20131244 https:\/\/doi.org\/10.1016\/S1473-3099(24)00376-1 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"744_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2025.100841","volume":"6","author":"EZ Ong","year":"2025","unstructured":"Ong, E. Z. et al. Dengue virus infection reprograms baseline innate immune gene expression. Med 6, 100841 https:\/\/doi.org\/10.1016\/j.medj.2025.100841 (2025).","journal-title":"Med"},{"key":"744_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2017.37","volume":"2","author":"S Aguirre","year":"2017","unstructured":"Aguirre, S. et al. Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection. Nat. Microbiol. 2, 1121 https:\/\/doi.org\/10.1038\/nmicrobiol.2017.37 (2017).","journal-title":"Nat. Microbiol."},{"key":"744_CR118","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1128\/JVI.02188-08","volume":"83","author":"J Ashour","year":"2009","unstructured":"Ashour, J., Laurent-Rolle, M., Shi, P.-Y. & Garc\u00eda-Sastre, A. NS5 of dengue virus mediates STAT2 binding and degradation. J. Virol. 83, 5408\u20135418 https:\/\/doi.org\/10.1128\/JVI.02188-08 (2009).","journal-title":"J. Virol."},{"key":"744_CR119","doi-asserted-by":"publisher","first-page":"8004","DOI":"10.1128\/JVI.79.13.8004-8013.2005","volume":"79","author":"JL Mu\u00f1oz-Jord\u00e1n","year":"2005","unstructured":"Mu\u00f1oz-Jord\u00e1n, J. L. et al. Inhibition of alpha\/beta interferon signaling by the NS4B protein of flaviviruses. J. Virol. 79, 8004\u20138013 https:\/\/doi.org\/10.1128\/JVI.79.13.8004-8013.2005 (2005).","journal-title":"J. Virol."},{"key":"744_CR120","doi-asserted-by":"publisher","first-page":"14333","DOI":"10.1073\/pnas.2335168100","volume":"100","author":"JL Mu\u00f1oz-Jordan","year":"2003","unstructured":"Mu\u00f1oz-Jordan, J. L., S\u00e1nchez-Burgos, G. G., Laurent-Rolle, M. & Garc\u00eda-Sastre, A. Inhibition of interferon signaling by dengue virus. Proc. Natl Acad. Sci. USA 100, 14333\u201314338 https:\/\/doi.org\/10.1073\/pnas.2335168100 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"744_CR121","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1126\/science.aab3369","volume":"350","author":"G Manokaran","year":"2015","unstructured":"Manokaran, G. et al. Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness. Science 350, 217\u2013221 https:\/\/doi.org\/10.1126\/science.aab3369 (2015).","journal-title":"Science"},{"key":"744_CR122","doi-asserted-by":"publisher","first-page":"11038","DOI":"10.1073\/pnas.1919287117","volume":"117","author":"A Syenina","year":"2020","unstructured":"Syenina, A. et al. Positive epistasis between viral polymerase and the 3\u2032 untranslated region of its genome reveals the epidemiologic fitness of dengue virus. Proc. Natl Acad. Sci. USA 117, 11038\u201311047 https:\/\/doi.org\/10.1073\/pnas.1919287117 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"744_CR123","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.cell.2018.11.028","volume":"175","author":"PS Shah","year":"2018","unstructured":"Shah, P. S. et al. Comparative flavivirus-host protein interaction mapping reveals mechanisms of dengue and Zika virus pathogenesis. Cell 175, 1931\u20131945.e18 https:\/\/doi.org\/10.1016\/j.cell.2018.11.028 (2018).","journal-title":"Cell"},{"key":"744_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-03110-9","volume":"24","author":"K-C Liao","year":"2023","unstructured":"Liao, K.-C. et al. Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells. Genome Biol. 24, 279 https:\/\/doi.org\/10.1186\/s13059-023-03110-9 (2023).","journal-title":"Genome Biol."},{"key":"744_CR125","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.chom.2025.06.006","volume":"33","author":"G Gonnella","year":"2025","unstructured":"Gonnella, G. et al. Immune profiling in subclinical secondary dengue-infected cases reveals adaptive immune signatures correlated to protection from severe dengue. Cell Host Microbe 33, 1191\u20131207.e4 https:\/\/doi.org\/10.1016\/j.chom.2025.06.006 (2025).","journal-title":"Cell Host Microbe"},{"key":"744_CR126","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ads5932","volume":"17","author":"W Sungnak","year":"2025","unstructured":"Sungnak, W. et al. Distinct systemic immune responses in asymptomatic and symptomatic dengue virus infection. Sci. Transl. Med. 17, eads5932 https:\/\/doi.org\/10.1126\/scitranslmed.ads5932 (2025).","journal-title":"Sci. Transl. Med."},{"key":"744_CR127","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4269\/ajtmh.2002.67.102","volume":"67","author":"H Loke","year":"2002","unstructured":"Loke, H. et al. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes. Am. J. Trop. Med. Hyg. 67, 102\u2013106\u00a0https:\/\/doi.org\/10.4269\/ajtmh.2002.67.102 (2002).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"744_CR128","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.4269\/ajtmh.2010.09-0353","volume":"82","author":"G Garcia","year":"2010","unstructured":"Garc\u00eda, G. et al. Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the Fc\u03b3RIIa polymorphism. Am. J. Trop. Med. Hyg. 82, 1153\u20131156 https:\/\/doi.org\/10.4269\/ajtmh.2010.09-0353 (2010).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"744_CR129","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1089\/vim.2015.0082","volume":"29","author":"IF Cansancao","year":"2016","unstructured":"Cansan\u00e7\u00e3o, I. F., do Carmo, A. P. S., Leite, R. D. & Rabenhorst, S. H. B. Association of polymorphisms in IL1\u03b2-511C>T, IL1RN 86 bp VNTR, and IL6\u00a0-174G>C genes with clinical dengue signs and symptoms in Brazilian dengue patients. Viral Immunol. 29, 372\u2013376 https:\/\/doi.org\/10.1089\/vim.2015.0082 (2016).","journal-title":"Viral Immunol."},{"key":"744_CR130","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00011-016-0975-5","volume":"65","author":"IF Cansancao","year":"2016","unstructured":"Cansan\u00e7\u00e3o, I. F. et al. Association of genetic polymorphisms of IL1\u03b2 -511 C>T, IL1RN VNTR 86 bp, IL6 -174 G>C, IL10 -819 C>T and TNF\u03b1 -308 G>A, involved in symptomatic patients with dengue in Brazil. Inflamm. Res. 65, 925\u2013932 https:\/\/doi.org\/10.1007\/s00011-016-0975-5 (2016).","journal-title":"Inflamm. Res."},{"key":"744_CR131","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.humimm.2007.03.001","volume":"68","author":"B Sierra","year":"2007","unstructured":"Sierra, B. et al. HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Hum. Immunol. 68, 531\u2013540 https:\/\/doi.org\/10.1016\/j.humimm.2007.03.001 (2007).","journal-title":"Hum. Immunol."},{"key":"744_CR132","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1086\/597422","volume":"199","author":"S Vejbaesya","year":"2009","unstructured":"Vejbaesya, S. et al. TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. J. Infect. Dis. 199, 1442\u20131448 https:\/\/doi.org\/10.1086\/597422 (2009).","journal-title":"J. Infect. Dis."},{"key":"744_CR133","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/ng.960","volume":"43","author":"CC Khor","year":"2011","unstructured":"Khor, C. C. et al. Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat. Genet. 43, 1139\u20131141 https:\/\/doi.org\/10.1038\/ng.960 (2011).","journal-title":"Nat. Genet."},{"key":"744_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60941-9","volume":"16","author":"M Gregorova","year":"2025","unstructured":"Gregorova, M. et al. Early NK-cell and T-cell dysfunction marks progression to severe dengue in patients with obesity and healthy weight. Nat. Commun. 16, 5569 https:\/\/doi.org\/10.1038\/s41467-025-60941-9 (2025).","journal-title":"Nat. Commun."},{"key":"744_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2026.128983","volume":"88","author":"CJX Tay","year":"2026","unstructured":"Tay, C. J. X. et al. Over-induction of innate immune responses suppresses T cell response to mRNA SARS-CoV-2 vaccination. Vaccine 88, 128983 https:\/\/doi.org\/10.1016\/j.vaccine.2026.128983 (2026).","journal-title":"Vaccine"},{"key":"744_CR136","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(18)32560-1","volume":"393","author":"A Wilder-Smith","year":"2019","unstructured":"Wilder-Smith, A., Ooi, E. E., Horstick, O. & Wills, B. Dengue. Lancet 393, 350\u2013363 https:\/\/doi.org\/10.1016\/S0140-6736(18)32560-1 (2019).","journal-title":"Lancet"},{"key":"744_CR137","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S1473-3099(20)30601-0","volume":"21","author":"S Sangkaew","year":"2021","unstructured":"Sangkaew, S. et al. Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis. Lancet Infect. Dis. 21, 1014\u20131026 https:\/\/doi.org\/10.1016\/S1473-3099(20)30601-0 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"744_CR138","doi-asserted-by":"publisher","first-page":"e2277","DOI":"10.1371\/journal.pntd.0002277","volume":"7","author":"M Michels","year":"2013","unstructured":"Michels, M. et al. The predictive diagnostic value of serial daily bedside ultrasonography for severe dengue in Indonesian adults. PLoS Negl. Trop. Dis. 7, e2277 https:\/\/doi.org\/10.1371\/journal.pntd.0002277 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2564","volume":"34","author":"V Campana","year":"2024","unstructured":"Campana, V. et al. Liver involvement in dengue: a systematic review. Rev. Med. Virol. 34, e2564 https:\/\/doi.org\/10.1002\/rmv.2564 (2024).","journal-title":"Rev. Med. Virol."},{"key":"744_CR140","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrcardio.2014.40","volume":"11","author":"S Yacoub","year":"2014","unstructured":"Yacoub, S., Wertheim, H., Simmons, C. P., Screaton, G. & Wills, B. Cardiovascular manifestations of the emerging dengue pandemic. Nat. Rev. Cardiol. 11, 335\u2013345 https:\/\/doi.org\/10.1038\/nrcardio.2014.40 (2014).","journal-title":"Nat. Rev. Cardiol."},{"key":"744_CR141","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.ophtha.2007.03.054","volume":"114","author":"DH-W Su","year":"2007","unstructured":"Su, D. H.-W. et al. Prevalence of dengue maculopathy in patients hospitalized for dengue fever. Ophthalmology 114, 1743\u20131747 https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.054 (2007).","journal-title":"Ophthalmology"},{"key":"744_CR142","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0140-6736(00)02036-5","volume":"355","author":"T Solomon","year":"2000","unstructured":"Solomon, T. et al. Neurological manifestations of dengue infection. Lancet 355, 1053\u20131059 https:\/\/doi.org\/10.1016\/S0140-6736(00)02036-5 (2000).","journal-title":"Lancet"},{"key":"744_CR143","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad373","volume":"10","author":"CD Odio","year":"2023","unstructured":"Odio, C. D. et al. The effect of age on dengue presentation and the diagnostic accuracy of the 2015 Pan American Health Organization case criteria in a Puerto Rican cohort. Open Forum Infect. Dis. 10, ofad128983 https:\/\/doi.org\/10.1093\/ofid\/ofad373 (2023).","journal-title":"Open Forum Infect. Dis."},{"key":"744_CR144","doi-asserted-by":"publisher","first-page":"971","DOI":"10.4269\/ajtmh.23-0717","volume":"110","author":"JE Salazar Florez","year":"2024","unstructured":"Salazar Fl\u00f3rez, J. E. et al. Clinical manifestations of dengue in children and adults in a hyperendemic region of Colombia. Am. J. Trop. Med. Hyg. 110, 971\u2013978 https:\/\/doi.org\/10.4269\/ajtmh.23-0717 (2024).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"744_CR145","doi-asserted-by":"publisher","first-page":"e1191","DOI":"10.1371\/journal.pntd.0001191","volume":"5","author":"JGH Low","year":"2011","unstructured":"Low, J. G. H. et al. The early clinical features of dengue in adults: challenges for early clinical diagnosis. PLoS Negl. Trop. Dis. 5, e1191 https:\/\/doi.org\/10.1371\/journal.pntd.0001191 (2011).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR146","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1590\/S1020-49892002000400003","volume":"11","author":"MG Guzm\u00e1n","year":"2002","unstructured":"Guzm\u00e1n, M. G. et al. Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Pan Am. J. Public Health\u00a011, 223\u2013227 https:\/\/doi.org\/10.1590\/s1020-49892002000400003 (2002).","journal-title":"Pan Am. J. Public Health"},{"key":"744_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2025.101088","volume":"6","author":"K Pillay","year":"2025","unstructured":"Pillay, K. et al. Evaluating the performance of common reference laboratory tests for acute dengue diagnosis: a systematic review and meta-analysis of RT-PCR, NS1 ELISA, and IgM ELISA. Lancet Microbe 6, 101088 https:\/\/doi.org\/10.1016\/j.lanmic.2025.101088 (2025).","journal-title":"Lancet Microbe"},{"key":"744_CR148","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4269\/ajtmh.2011.10-0316","volume":"84","author":"S Chaterji","year":"2011","unstructured":"Chaterji, S., Allen, J. C. Jr, Chow, A., Leo, Y.-S. & Ooi, E. E. Evaluation of the NS1 rapid test and the WHO dengue classification schemes for use as bedside diagnosis of acute dengue fever in adults. Am. J. Trop. Med. Hyg. 84, 224\u2013228 https:\/\/doi.org\/10.4269\/ajtmh.2011.10-0316 (2011).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"744_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91099-5","volume":"15","author":"DA Muller","year":"2025","unstructured":"Muller, D. A. et al. Kinetics of NS1 and anti-NS1 IgG following dengue infection reveals likely early formation of immune complexes in secondary infected patients. Sci. Rep. 15, 6684 https:\/\/doi.org\/10.1038\/s41598-025-91099-5 (2025).","journal-title":"Sci. Rep."},{"key":"744_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/srep27663","volume":"6","author":"B-T Teoh","year":"2016","unstructured":"Teoh, B.-T. et al. The use of NS1 rapid diagnostic test and qRT-PCR to complement IgM ELISA for improved dengue diagnosis from single specimen. Sci. Rep. 6, 128983 https:\/\/doi.org\/10.1038\/srep27663 (2016).","journal-title":"Sci. Rep."},{"key":"744_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3274-7","volume":"18","author":"THT Nguyen","year":"2018","unstructured":"Nguyen, T. H. T. et al. Methods to discriminate primary from secondary dengue during acute symptomatic infection. BMC Infect. Dis. 18, 375 https:\/\/doi.org\/10.1186\/s12879-018-3274-7 (2018).","journal-title":"BMC Infect. Dis."},{"key":"744_CR152","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00431-026-06963-x","volume":"185","author":"KH Padma Priya","year":"2026","unstructured":"Padma Priya, K. H., Gerin, P. & Thiruvengadam, V. Predictive value of quantitative NS1 antigen, IgM and IgG antibody titres in assessing dengue severity in children. Eur. J. Pediatr. 185, 311 https:\/\/doi.org\/10.1007\/s00431-026-06963-x (2026).","journal-title":"Eur. J. Pediatr."},{"key":"744_CR153","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/cid\/cix966","volume":"66","author":"E Plennevaux","year":"2018","unstructured":"Plennevaux, E. et al. Impact of dengue vaccination on serological diagnosis: insights from phase III dengue vaccine efficacy trials. Clin. Infect. Dis. 66, 1164\u20131172 https:\/\/doi.org\/10.1093\/cid\/cix966 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"744_CR154","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4269\/ajtmh.23-0549","volume":"111","author":"JG Low","year":"2024","unstructured":"Low, J. G. et al. IgG, IgM, and nonstructural protein 1 response profiles after receipt of tetravalent dengue vaccine TAK-003 in a phase 2 randomized controlled trial. Am. J. Trop. Med. Hyg. 111, 102\u2013106 https:\/\/doi.org\/10.4269\/ajtmh.23-0549 (2024).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"744_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105164","volume":"104","author":"S Karolcik","year":"2024","unstructured":"Karolcik, S. et al. Towards a machine-learning assisted non-invasive classification of dengue severity using wearable PPG data: a prospective clinical study. eBioMedicine 104, 105164 https:\/\/doi.org\/10.1016\/j.ebiom.2024.105164 (2024).","journal-title":"eBioMedicine"},{"key":"744_CR156","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41746-024-01304-4","volume":"7","author":"DK Ming","year":"2024","unstructured":"Ming, D. K. et al. Predicting deterioration in dengue using a low cost wearable for continuous clinical monitoring. npj Digit. Med. 7, 306 https:\/\/doi.org\/10.1038\/s41746-024-01304-4 (2024).","journal-title":"npj Digit. Med."},{"key":"744_CR157","doi-asserted-by":"publisher","first-page":"e0000924","DOI":"10.1371\/journal.pdig.0000924","volume":"4","author":"NN Lyle","year":"2025","unstructured":"Lyle, N. N. et al. An artificial intelligence-based approach to identify volume status in patients with severe dengue using wearable PPG data. PLoS Digit. Health 4, e0000924 https:\/\/doi.org\/10.1371\/journal.pdig.0000924 (2025).","journal-title":"PLoS Digit. Health"},{"key":"744_CR158","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","volume":"373","author":"SR Hadinegoro","year":"2015","unstructured":"Hadinegoro, S. R. et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N. Engl. J. Med. 373, 1195\u20131206 https:\/\/doi.org\/10.1056\/NEJMoa1506223 (2015).","journal-title":"N. Engl. J. Med."},{"key":"744_CR159","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/S2214-109X(23)00522-3","volume":"12","author":"V Tricou","year":"2024","unstructured":"Tricou, V. et al. Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4\u00b75-year results from a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Glob. Health 12, e257\u2013e270 https:\/\/doi.org\/10.1016\/S2214-109X(23)00522-3 (2024).","journal-title":"Lancet Glob. Health"},{"key":"744_CR160","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/s41591-026-04255-3","volume":"32","author":"EG Kall\u00e1s","year":"2026","unstructured":"Kall\u00e1s, E. G. et al. Long-term efficacy and safety of the single-dose tetravalent Butantan dengue vaccine. Nat. Med. 32, 1393\u20131400 https:\/\/doi.org\/10.1038\/s41591-026-04255-3 (2026).","journal-title":"Nat. Med."},{"key":"744_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00658-2","volume":"8","author":"SJ Thomas","year":"2023","unstructured":"Thomas, S. J. Is new dengue vaccine efficacy data a relief or cause for concern? npj Vaccines 8, 55 https:\/\/doi.org\/10.1038\/s41541-023-00658-2 (2023).","journal-title":"npj Vaccines"},{"key":"744_CR162","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","volume":"384","author":"MR Capeding","year":"2014","unstructured":"Capeding, M. R. et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 384, 1358\u20131365 https:\/\/doi.org\/10.1016\/s0140-6736(14)61060-6 (2014).","journal-title":"Lancet"},{"key":"744_CR163","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1411037","volume":"372","author":"L Villar","year":"2014","unstructured":"Villar, L. et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. N. Engl. J. Med. 372, 113\u20131121 https:\/\/doi.org\/10.1056\/NEJMoa1411037 (2014).","journal-title":"N. Engl. J. Med."},{"key":"744_CR164","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/nejmoa1800820","volume":"379","author":"S Sridhar","year":"2018","unstructured":"Sridhar, S. et al. Effect of dengue serostatus on dengue vaccine safety and efficacy. N. Engl. J. Med. 379, 327\u2013340 https:\/\/doi.org\/10.1056\/nejmoa1800820 (2018).","journal-title":"N. Engl. J. Med."},{"key":"744_CR165","unstructured":"World Health Organization. Guidelines on the Quality, Safety and Efficacy of Dengue Tetravalent Vaccines (Live, Attenuated) Technical Report Series No. 979 https:\/\/www.who.int\/publications\/m\/item\/TRS_979_annex-2-dengue (WHO, 2013)."},{"key":"744_CR166","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00670-6","volume":"8","author":"I LeFevre","year":"2023","unstructured":"LeFevre, I. et al. Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults. npj Vaccines 8, 75 https:\/\/doi.org\/10.1038\/s41541-023-00670-6 (2023).","journal-title":"npj Vaccines"},{"key":"744_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2026.128373","volume":"77","author":"S Mandaric","year":"2026","unstructured":"Mandaric, S. et al. Humoral and cellular responses to a tetravalent dengue vaccine (TAK-003) in adults from a dengue non-endemic region: an open-label phase 2 trial. Vaccine 77, 128373 https:\/\/doi.org\/10.1016\/j.vaccine.2026.128373 (2026).","journal-title":"Vaccine"},{"key":"744_CR168","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJMoa2301790","volume":"390","author":"EG Kall\u00e1s","year":"2024","unstructured":"Kall\u00e1s, E. G. et al. Live, attenuated, tetravalent Butantan\u2013dengue vaccine in children and adults. N. Engl. J. Med. 390, 397\u2013408 https:\/\/doi.org\/10.1056\/NEJMoa2301790 (2024).","journal-title":"N. Engl. J. Med."},{"key":"744_CR169","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2046960","volume":"18","author":"KL Russell","year":"2022","unstructured":"Russell, K. L. et al. A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-na\u00efve and flavivirus-experienced healthy adults. Hum. Vaccines Immunother. 18, 2046960 https:\/\/doi.org\/10.1080\/21645515.2022.2046960 (2022).","journal-title":"Hum. Vaccines Immunother."},{"key":"744_CR170","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciag349","author":"D Alexanderian","year":"2026","unstructured":"Alexanderian, D. et al. Safety and immunogenicity of the live-attenuated quadrivalent dengue vaccine V181 compared with Butantan-DV among healthy adults in Brazil: a randomized, double-blind, phase 2 trial. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciag349 (2026).","journal-title":"Clin. Infect. Dis."},{"key":"744_CR171","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick, L. C. et al. Antibody-dependent enhancement of severe dengue disease in humans. Science 358, 929\u2013932 https:\/\/doi.org\/10.1126\/science.aan6836 (2017).","journal-title":"Science"},{"key":"744_CR172","doi-asserted-by":"publisher","first-page":"e1003723","DOI":"10.1371\/journal.ppat.1003723","volume":"9","author":"RM Zellweger","year":"2013","unstructured":"Zellweger, R. M. et al. Role of humoral versus cellular responses induced by a protective dengue vaccine candidate. PLoS Pathog. 9, e1003723 https:\/\/doi.org\/10.1371\/journal.ppat.1003723 (2013).","journal-title":"PLoS Pathog."},{"key":"744_CR173","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ebiom.2016.10.006","volume":"13","author":"A Elong Ngono","year":"2016","unstructured":"Elong Ngono, A. et al. Protective role of cross-reactive CD8 T cells against dengue virus infection. eBioMedicine 13, 284\u2013293 https:\/\/doi.org\/10.1016\/j.ebiom.2016.10.006 (2016).","journal-title":"eBioMedicine"},{"key":"744_CR174","doi-asserted-by":"publisher","first-page":"e179771","DOI":"10.1172\/jci.insight.179771","volume":"10","author":"RI G\u00e1lvez","year":"2025","unstructured":"G\u00e1lvez, R. I. et al. Frequency of dengue virus-specific T cells is related to infection outcome in endemic settings. JCI Insight 10, e179771 https:\/\/doi.org\/10.1172\/jci.insight.179771 (2025).","journal-title":"JCI Insight"},{"key":"744_CR175","doi-asserted-by":"publisher","first-page":"uxag049","DOI":"10.1093\/cei\/uxag049","volume":"220","author":"H Kuruppu","year":"2026","unstructured":"Kuruppu, H. et al. Severity-associated changes in ICOS, CD27, CD127 and CLA expression and expansion of virus-specific T cells in acute dengue. Clin. Exp. Immunol. 220, uxag049 https:\/\/doi.org\/10.1093\/cei\/uxag049 (2026).","journal-title":"Clin. Exp. Immunol."},{"key":"744_CR176","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1016\/j.vaccine.2008.08.019","volume":"26","author":"B Guy","year":"2008","unstructured":"Guy, B. et al. Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects. Vaccine 26, 5712\u20135721 https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.019 (2008).","journal-title":"Vaccine"},{"key":"744_CR177","doi-asserted-by":"publisher","first-page":"e00089","DOI":"10.1128\/JVI.00089-20","volume":"94","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species. J. Virol. 94, e00089\u201320 https:\/\/doi.org\/10.1128\/JVI.00089-20 (2020).","journal-title":"J. Virol."},{"key":"744_CR178","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1128\/JVI.02129-14","volume":"89","author":"D Weiskopf","year":"2015","unstructured":"Weiskopf, D. et al. The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes. J. Virol. 89, 120\u2013128\u00a0https:\/\/doi.org\/10.1128\/JVI.02129-14 (2015).","journal-title":"J. Virol."},{"key":"744_CR179","doi-asserted-by":"publisher","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","volume":"110","author":"D Weiskopf","year":"2013","unstructured":"Weiskopf, D. et al. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc. Natl Acad. Sci. USA 110, E2046\u2013E2053 https:\/\/doi.org\/10.1073\/pnas.1305227110 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"744_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2026.128510","volume":"79","author":"JSG Ooi","year":"2026","unstructured":"Ooi, J. S. G. et al. Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humans. Vaccine 79, 128510 https:\/\/doi.org\/10.1016\/j.vaccine.2026.128510 (2026).","journal-title":"Vaccine"},{"key":"744_CR181","doi-asserted-by":"publisher","first-page":"106707","DOI":"10.1016\/j.jinf.2026.106707","volume":"92","author":"A D\u2019Abramo","year":"2026","unstructured":"D\u2019Abramo, A. et al. The DENGVAC study: preliminary findings on the immunogenicity of the TAK-003 dengue vaccine. J. Infect. 92, 106707 https:\/\/doi.org\/10.1016\/j.jinf.2026.106707 (2026).","journal-title":"J. Infect."},{"key":"744_CR182","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1473-3099(25)00382-2","volume":"26","author":"OT Ranzani","year":"2026","unstructured":"Ranzani, O. T. et al. Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in S\u00e3o Paulo, Brazil: a test-negative, case-control study. Lancet Infect. Dis. 26, 91\u2013100\u00a0https:\/\/doi.org\/10.1016\/S1473-3099(25)00382-2 (2026).","journal-title":"Lancet Infect. Dis."},{"key":"744_CR183","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.medj.2021.04.003","volume":"2","author":"S Kalimuddin","year":"2021","unstructured":"Kalimuddin, S. et al. Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset. Med 2, 682\u2013688.e684 https:\/\/doi.org\/10.1016\/j.medj.2021.04.003 (2021).","journal-title":"Med"},{"key":"744_CR184","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1093\/infdis\/jir607","volume":"204","author":"A Mathew","year":"2011","unstructured":"Mathew, A. et al. B-cell responses during primary and secondary dengue virus infections in humans. J. Infect. Dis. 204, 1514\u20131522 https:\/\/doi.org\/10.1093\/infdis\/jir607 (2011).","journal-title":"J. Infect. Dis."},{"key":"744_CR185","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/infdis\/jiaa120","volume":"222","author":"P Andrade","year":"2020","unstructured":"Andrade, P. et al. Primary and secondary dengue virus infections elicit similar memory B-cell responses, but breadth to other serotypes and cross-reactivity to Zika virus is higher in secondary dengue. J. Infect. Dis. 222, 590\u2013600 https:\/\/doi.org\/10.1093\/infdis\/jiaa120 (2020).","journal-title":"J. Infect. Dis."},{"key":"744_CR186","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/infdis\/jiaa346","volume":"223","author":"D Michlmayr","year":"2021","unstructured":"Michlmayr, D. et al. Characterization of the type-specific and cross-reactive B-cell responses elicited by a live-attenuated tetravalent dengue vaccine. J. Infect. Dis. 223, 247\u2013257 https:\/\/doi.org\/10.1093\/infdis\/jiaa346 (2021).","journal-title":"J. Infect. Dis."},{"key":"744_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100155","volume":"1","author":"HA Tu","year":"2020","unstructured":"Tu, H. A. et al. Stimulation of B cell immunity in flavivirus-naive individuals by the tetravalent live attenuated dengue vaccine TV003. Cell Rep. Med. 1, 1121 https:\/\/doi.org\/10.1016\/j.xcrm.2020.100155 (2020).","journal-title":"Cell Rep. Med."},{"key":"744_CR188","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21384-0","volume":"12","author":"UK Nivarthi","year":"2021","unstructured":"Nivarthi, U. K. et al. A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans. Nat. Commun. 12, 1102 https:\/\/doi.org\/10.1038\/s41467-021-21384-0 (2021).","journal-title":"Nat. Commun."},{"key":"744_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.108023","volume":"159","author":"IT Peres","year":"2025","unstructured":"Peres, I. T. et al. Clinical characteristics, complications and outcomes of critically ill patients with dengue in Brazil, 2012-2024: a nationwide, multicenter cohort study. Int. J. Infect. Dis. 159, 108023 https:\/\/doi.org\/10.1016\/j.ijid.2025.108023 (2025).","journal-title":"Int. J. Infect. Dis."},{"key":"744_CR190","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28387-w","volume":"8","author":"ES Paixao","year":"2018","unstructured":"Paix\u00e3o, E. S. et al. Dengue in pregnancy and maternal mortality: a cohort analysis using routine data. Sci. Rep. 8, 9938 https:\/\/doi.org\/10.1038\/s41598-018-28387-w (2018).","journal-title":"Sci. Rep."},{"key":"744_CR191","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S1473-3099(16)00088-8","volume":"16","author":"ES Paix\u00e3o","year":"2016","unstructured":"Paix\u00e3o, E. S., Teixeira, M. G., Costa, M. d. C. N. & Rodrigues, L. C. Dengue during pregnancy and adverse fetal outcomes: a systematic review and meta-analysis. Lancet Infect. Dis. 16, 857\u2013865 https:\/\/doi.org\/10.1016\/S1473-3099(16)00088-8 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"744_CR192","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.trstmh.2010.05.003","volume":"104","author":"I-K Lee","year":"2010","unstructured":"Lee, I.-K., Lee, W.-H., Yang, K. D. & Liu, J.-W. Comparison of the effects of oral hydration and intravenous fluid replacement in adult patients with non-shock dengue hemorrhagic fever in Taiwan. Trans. R. Soc. Trop. Med. Hyg. 104, 541\u2013545\u00a0https:\/\/doi.org\/10.1016\/j.trstmh.2010.05.003 (2010).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"744_CR193","doi-asserted-by":"publisher","unstructured":"Moxon, C. & Wills, B. Management of severe dengue in children. In Hot Topics in Infection and Immunity in Children IV\u00a0(eds Finn, A. & Pollard, A. J.)\u00a0131\u2013144 https:\/\/doi.org\/10.1007\/978-0-387-73960-1_10 (Springer, 2008).","DOI":"10.1007\/978-0-387-73960-1_10"},{"key":"744_CR194","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa044057","volume":"353","author":"BA Wills","year":"2005","unstructured":"Wills, B. A. et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N. Engl. J. Med. 353, 877\u2013889 https:\/\/doi.org\/10.1056\/NEJMoa044057 (2005).","journal-title":"N. Engl. J. Med."},{"key":"744_CR195","doi-asserted-by":"publisher","first-page":"e017538","DOI":"10.1136\/bmjgh-2024-017538","volume":"10","author":"HT Trieu","year":"2025","unstructured":"Trieu, H. T. et al. The influence of fluid resuscitation strategy on outcomes from dengue shock syndrome: a review of the management of 691 children in 7 Southeast Asian hospitals. BMJ Glob. Health 10, e017538 https:\/\/doi.org\/10.1136\/bmjgh-2024-017538 (2025).","journal-title":"BMJ Glob. Health"},{"key":"744_CR196","doi-asserted-by":"publisher","first-page":"e0005740","DOI":"10.1371\/journal.pntd.0005740","volume":"11","author":"S Yacoub","year":"2017","unstructured":"Yacoub, S. et al. Cardio-haemodynamic assessment and venous lactate in severe dengue: relationship with recurrent shock and respiratory distress. PLoS Negl. Trop. Dis. 11, e0005740 https:\/\/doi.org\/10.1371\/journal.pntd.0005740 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR197","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1097\/PCC.0000000000003413","volume":"25","author":"LT Vo","year":"2024","unstructured":"Vo, L. T. et al. Pediatric profound dengue shock syndrome and use of point-of-care ultrasound during mechanical ventilation to guide treatment: single-center retrospective study, 2013\u20132021. Pediatr. Crit. Care Med. 25, e177\u2013e185 https:\/\/doi.org\/10.1097\/PCC.0000000000003413 (2024).","journal-title":"Pediatr. Crit. Care Med."},{"key":"744_CR198","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/cid\/cit594","volume":"57","author":"PK Lam","year":"2013","unstructured":"Lam, P. K. et al. Clinical characteristics of dengue shock syndrome in Vietnamese children: a 10-year prospective study in a single hospital. Clin. Infect. Dis. 57, 1577\u20131586 https:\/\/doi.org\/10.1093\/cid\/cit594 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"744_CR199","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.4269\/ajtmh.16-0374","volume":"95","author":"KK Mon","year":"2016","unstructured":"Mon, K. K. et al. Incidence and clinical outcome of acute liver failure caused by dengue in a hospital for tropical diseases, Thailand. Am. J. Trop. Med. Hyg. 95, 1338\u20131344 https:\/\/doi.org\/10.4269\/ajtmh.16-0374 (2016).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"744_CR200","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06681-9","volume":"21","author":"DMDIB Dissanayake","year":"2021","unstructured":"Dissanayake, D. M. D. I. B., Gunaratne, W. M. S. N., Kumarihamy, K. W. M. P. P., Kularatne, S. A. M. & Kumarasiri, P. V. R. Use of intravenous N-acetylcysteine in acute severe hepatitis due to severe dengue infection: a case series. BMC Infect. Dis. 21, 978 https:\/\/doi.org\/10.1186\/s12879-021-06681-9 (2021).","journal-title":"BMC Infect. Dis."},{"key":"744_CR201","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/S0140-6736(17)30269-6","volume":"389","author":"DC Lye","year":"2017","unstructured":"Lye, D. C. et al. Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial. Lancet 389, 1611\u20131618 https:\/\/doi.org\/10.1016\/S0140-6736(17)30269-6 (2017).","journal-title":"Lancet"},{"key":"744_CR202","doi-asserted-by":"publisher","first-page":"e004043","DOI":"10.1136\/bmjph-2025-004043","volume":"4","author":"A McBride","year":"2026","unstructured":"McBride, A. et al. Dengue therapeutics consortium 2025: a global collaboration in action. BMJ Public Health 4, e004043 https:\/\/doi.org\/10.1136\/bmjph-2025-004043 (2026).","journal-title":"BMJ Public Health"},{"key":"744_CR203","doi-asserted-by":"publisher","first-page":"eabb2181","DOI":"10.1126\/scitranslmed.abb2181","volume":"13","author":"SA Moquin","year":"2021","unstructured":"Moquin, S. A. et al. NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models. Sci. Transl. Med. 13, eabb2181 https:\/\/doi.org\/10.1126\/scitranslmed.abb2181 (2021).","journal-title":"Sci. Transl. Med."},{"key":"744_CR204","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06006559 (2026)."},{"key":"744_CR205","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1056\/NEJMoa2500179","volume":"393","author":"AP Durbin","year":"2025","unstructured":"Durbin, A. P. et al. Daily mosnodenvir as dengue prophylaxis in a controlled human infection model. N. Engl. J. Med. 393, 2107\u20132118 https:\/\/doi.org\/10.1056\/NEJMoa2500179 (2025).","journal-title":"N. Engl. J. Med."},{"key":"744_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2025.110677","volume":"612","author":"I Terzi","year":"2025","unstructured":"Terzi, I. et al. Neutralizing monoclonal antibodies against dengue virus: a scoping review of preclinical and clinical development. Virology 612, 110677 https:\/\/doi.org\/10.1016\/j.virol.2025.110677 (2025).","journal-title":"Virology"},{"key":"744_CR207","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62423-4","volume":"16","author":"JH Kim","year":"2025","unstructured":"Kim, J. H. et al. A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19. Nat. Commun. 16, 7084 https:\/\/doi.org\/10.1038\/s41467-025-62423-4 (2025).","journal-title":"Nat. Commun."},{"key":"744_CR208","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT07576868 (2026)."},{"key":"744_CR209","doi-asserted-by":"publisher","first-page":"e0006209","DOI":"10.1371\/journal.pntd.0006209","volume":"12","author":"Y Budigi","year":"2018","unstructured":"Budigi, Y. et al. Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein. PLoS Negl. Trop. Dis. 12, e0006209 https:\/\/doi.org\/10.1371\/journal.pntd.0006209 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR210","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S1473-3099(24)00030-6","volume":"24","author":"B Gunale","year":"2024","unstructured":"Gunale, B. et al. An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia. Lancet Infect. Dis. 24, 639\u2013649 https:\/\/doi.org\/10.1016\/S1473-3099(24)00030-6 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"744_CR211","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06551844 (2026)."},{"key":"744_CR212","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06799741 (2026)."},{"key":"744_CR213","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0147-9","volume":"12","author":"S Yacoub","year":"2014","unstructured":"Yacoub, S. & Wills, B. Predicting outcome from dengue. BMC Med. 12, 147 https:\/\/doi.org\/10.1186\/s12916-014-0147-9 (2014).","journal-title":"BMC Med."},{"key":"744_CR214","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/infdis\/jiac093","volume":"226","author":"NL Vuong","year":"2022","unstructured":"Vuong, N. L. et al. Hyperinflammatory syndrome, natural killer cell function and genetic polymorphisms in the pathogenesis of severe dengue. J. Infect. Dis. 226, 1338\u20131347 https:\/\/doi.org\/10.1093\/infdis\/jiac093 (2022).","journal-title":"J. Infect. Dis."},{"key":"744_CR215","doi-asserted-by":"publisher","first-page":"e0014382","DOI":"10.1371\/journal.pntd.0014382","volume":"20","author":"TB Huyen","year":"2026","unstructured":"Huyen, T. B. et al. A systematic mapping review of therapeutic clinical trials in dengue. PLoS Negl. Trop. Dis. 20, e0014382 https:\/\/doi.org\/10.1371\/journal.pntd.0014382 (2026).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR216","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/S2666-5247(21)00087-2","volume":"2","author":"A McBride","year":"2021","unstructured":"McBride, A., Mehta, P., Rivino, L., Ramanan, A. V. & Yacoub, S. Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought? Lancet Microbe 2, e277\u2013e278 https:\/\/doi.org\/10.1016\/S2666-5247(21)00087-2 (2021).","journal-title":"Lancet Microbe"},{"key":"744_CR217","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003488.pub3","author":"F Zhang","year":"2014","unstructured":"Zhang, F. & Kramer, C. V. Corticosteroids for dengue infection. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD003488.pub3 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"744_CR218","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/cid\/cis655","volume":"55","author":"DT Tam","year":"2012","unstructured":"Tam, D. T. et al. Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin. Infect. Dis. 55, 1216\u20131224 https:\/\/doi.org\/10.1093\/cid\/cis655 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"744_CR219","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05631405 (2026)."},{"key":"744_CR220","doi-asserted-by":"publisher","DOI":"10.21542\/gcsp.2020.29","volume":"2020","author":"A McBride","year":"2020","unstructured":"McBride, A., Chanh, H. Q., Fraser, J. F., Yacoub, S. & Obonyo, N. G. Microvascular dysfunction in septic and dengue shock: pathophysiology and implications for clinical management. Glob. Cardiol. Sci. Pract. 2020, e202029 https:\/\/doi.org\/10.21542\/gcsp.2020.29 (2020).","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"744_CR221","doi-asserted-by":"publisher","first-page":"e0012071","DOI":"10.1371\/journal.pntd.0012071","volume":"18","author":"A McBride","year":"2024","unstructured":"McBride, A. et al. Endothelial and inflammatory pathophysiology in dengue shock: new insights from a prospective cohort study in Vietnam. PLoS Negl. Trop. Dis. 18, e0012071 https:\/\/doi.org\/10.1371\/journal.pntd.0012071 (2024).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR222","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06917001 (2025)."},{"key":"744_CR223","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04597437 (2025)."},{"key":"744_CR224","doi-asserted-by":"publisher","first-page":"e0011927","DOI":"10.1371\/journal.pntd.0011927","volume":"18","author":"N Nitinai","year":"2024","unstructured":"Nitinai, N. et al. Effect of montelukast in preventing dengue with warning signs among patients with dengue: a multicenter, randomized, double-blind, placebo-controlled trial. PLoS Negl. Trop. Dis. 18, e0011927 https:\/\/doi.org\/10.1371\/journal.pntd.0011927 (2024).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR225","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06747130 (2025)."},{"key":"744_CR226","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/cid\/civ949","volume":"62","author":"J Whitehorn","year":"2016","unstructured":"Whitehorn, J. et al. Lovastatin for the treatment of adult patients with dengue: a randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 62, 468\u2013476 https:\/\/doi.org\/10.1093\/cid\/civ949 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"744_CR227","doi-asserted-by":"publisher","first-page":"e0013281","DOI":"10.1371\/journal.pntd.0013281","volume":"19","author":"NM Nguyen","year":"2025","unstructured":"Nguyen, N. M. et al. Safety and tolerability of metformin in overweight and obese patients with dengue: an open-label clinical trial (MeDO). PLoS Negl. Trop. Dis. 19, e0013281 https:\/\/doi.org\/10.1371\/journal.pntd.0013281 (2025).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR228","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT07016321 (2026)."},{"key":"744_CR229","doi-asserted-by":"publisher","first-page":"e1121","DOI":"10.1371\/journal.pntd.0013889","volume":"20","author":"S Kalimuddin","year":"2026","unstructured":"Kalimuddin, S. et al. Proceedings of the inaugural symposium on dengue human challenge studies \u201cchallenging the norm: accelerating dengue countermeasures through human studies\u201d. PLoS Negl. Trop. Dis. 20, e1121 https:\/\/doi.org\/10.1371\/journal.pntd.0013889 (2026).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR230","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT07543458 (2026)."},{"key":"744_CR231","doi-asserted-by":"publisher","first-page":"e1121","DOI":"10.1371\/journal.pdig.0000005","volume":"1","author":"DK Ming","year":"2022","unstructured":"Ming, D. K. et al. Applied machine learning for the risk-stratification and clinical decision support of hospitalised patients with dengue in Vietnam. PLoS Digit. Health 1, e1121 https:\/\/doi.org\/10.1371\/journal.pdig.0000005 (2022).","journal-title":"PLoS Digit. Health"},{"key":"744_CR232","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1038\/s41591-025-03964-5","volume":"31","author":"BP Scicluna","year":"2025","unstructured":"Scicluna, B. P. et al. A consensus blood transcriptomic framework for sepsis. Nat. Med. 31, 4119\u20134130 https:\/\/doi.org\/10.1038\/s41591-025-03964-5 (2025).","journal-title":"Nat. Med."},{"key":"744_CR233","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0140-6736(08)61452-X","volume":"372","author":"GP Anderson","year":"2008","unstructured":"Anderson, G. P. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372, 1107\u20131119 https:\/\/doi.org\/10.1016\/S0140-6736(08)61452-X (2008).","journal-title":"Lancet"},{"key":"744_CR234","doi-asserted-by":"publisher","first-page":"732","DOI":"10.4269\/ajtmh.2011.11-0067","volume":"85","author":"CM Martelli","year":"2011","unstructured":"Martelli, C. M. et al. Quality of life among adults with confirmed dengue in Brazil. Am. J. Trop. Med. Hyg. 85, 732\u2013738 https:\/\/doi.org\/10.4269\/ajtmh.2011.11-0067 (2011).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"744_CR235","doi-asserted-by":"publisher","first-page":"e0008477","DOI":"10.1371\/journal.pntd.0008477","volume":"14","author":"WH Elson","year":"2020","unstructured":"Elson, W. H. et al. Measuring health related quality of life for dengue patients in Iquitos, Peru. PLoS Negl. Trop. Dis. 14, e0008477 https:\/\/doi.org\/10.1371\/journal.pntd.0008477 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR236","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3201\/eid2604.190729","volume":"26","author":"A Schulte","year":"2020","unstructured":"Schulte, A. et al. Health-related quality of life after dengue fever, Morelos, Mexico, 2016\u20132017. Emerg. Infect. Dis. 26, 751\u2013755 https:\/\/doi.org\/10.3201\/eid2604.190729 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"744_CR237","doi-asserted-by":"publisher","first-page":"862","DOI":"10.4269\/ajtmh.2008.78.862","volume":"78","author":"LCS Lum","year":"2008","unstructured":"Lum, L. C. S., Suaya, J. A., Tan, L. H., Sah, B. K. & Shepard, D. S. Quality of life of dengue patients. Am. J. Trop. Med. Hyg. 78, 862\u2013867 https:\/\/doi.org\/10.4269\/ajtmh.2008.78.862 (2008).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"744_CR238","doi-asserted-by":"publisher","first-page":"e0010724","DOI":"10.1371\/journal.pntd.0010724","volume":"16","author":"S Kalimuddin","year":"2022","unstructured":"Kalimuddin, S. et al. Chronic sequelae complicate convalescence from both dengue and acute viral respiratory illness. PLoS Negl. Trop. Dis. 16, e0010724 https:\/\/doi.org\/10.1371\/journal.pntd.0010724 (2022).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR239","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4269\/ajtmh.13-0544","volume":"90","author":"ES Halsey","year":"2014","unstructured":"Halsey, E. S. et al. Occurrence and correlates of symptom persistence following acute dengue fever in Peru. Am. J. Trop. Med. Hyg. 90, 449\u2013456 https:\/\/doi.org\/10.4269\/ajtmh.13-0544 (2014).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"744_CR240","doi-asserted-by":"publisher","DOI":"10.1590\/s1678-9946201759065","volume":"59","author":"LAS Teixeira","year":"2017","unstructured":"Teixeira, L. A. S., Nogueira, F. & Nascentes, G. A. N. Prospective study of patients with persistent symptoms of dengue in Brazil. Rev. Inst. Med. Trop. S\u00e3o Paulo 59, e65 https:\/\/doi.org\/10.1590\/S1678-9946201759065 (2017).","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"744_CR241","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/trstmh\/traa110","volume":"115","author":"PC Sigera","year":"2021","unstructured":"Sigera, P. C. et al. Dengue and post-infection fatigue: findings from a prospective cohort-the Colombo Dengue Study. Trans. R. Soc. Trop. Med. Hyg. 115, 669\u2013676 https:\/\/doi.org\/10.1093\/trstmh\/traa110 (2021).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"744_CR242","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1016\/j.ijid.2010.09.008","volume":"15","author":"G Garc\u00eda","year":"2011","unstructured":"Garc\u00eda, G. et al. Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. Int. J. Infect. Dis. 15, e38\u2013e43 https:\/\/doi.org\/10.1016\/j.ijid.2010.09.008 (2011).","journal-title":"Int. J. Infect. Dis."},{"key":"744_CR243","doi-asserted-by":"publisher","first-page":"taag037","DOI":"10.1093\/jtm\/taag037","volume":"33","author":"DH Hamer","year":"2026","unstructured":"Hamer, D. H. et al. Frequency and persistence of post-acute symptoms after chikungunya, dengue, Zika and malaria in travellers: a prospective multi-centre study. J. Travel Med. 33, taag037 https:\/\/doi.org\/10.1093\/jtm\/taag037 (2026).","journal-title":"J. Travel Med."},{"key":"744_CR244","doi-asserted-by":"publisher","first-page":"taae081","DOI":"10.1093\/jtm\/taae081","volume":"31","author":"LE Wee","year":"2024","unstructured":"Wee, L. E. et al. Dengue versus COVID-19: comparing the incidence of cardiovascular, neuropsychiatric and autoimmune complications. J. Travel Med. 31, taae081 https:\/\/doi.org\/10.1093\/jtm\/taae081 (2024).","journal-title":"J. Travel Med"},{"key":"744_CR245","doi-asserted-by":"publisher","first-page":"e2410075","DOI":"10.1001\/jamanetworkopen.2024.10075","volume":"7","author":"H-C Lin","year":"2024","unstructured":"Lin, H.-C. et al. Neurological or psychiatric disorders after dengue fever. JAMA Netw. Open 7, e2410075 https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.10075 (2024).","journal-title":"JAMA Netw. Open"},{"key":"744_CR246","doi-asserted-by":"publisher","first-page":"e0012239","DOI":"10.1371\/journal.pntd.0012239","volume":"18","author":"H-I Shih","year":"2024","unstructured":"Shih, H.-I., Wang, Y.-P., Chi, C.-Y. & Chien, Y.-W. Risks of anxiety disorders, depressive disorders, and sleep disorders in patients with dengue fever: a nationwide, population-based cohort study. PLoS Negl. Trop. Dis. 18, e0012239 https:\/\/doi.org\/10.1371\/journal.pntd.0012239 (2024).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR247","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.cmi.2025.06.012","volume":"31","author":"JT Lim","year":"2025","unstructured":"Lim, J. T. et al. Characterization of post-acute multi-organ sequelae following dengue infection. Clin. Microbiol. Infect. 31, 1865\u20131121 https:\/\/doi.org\/10.1016\/j.cmi.2025.06.012 (2025).","journal-title":"Clin. Microbiol. Infect."},{"key":"744_CR248","doi-asserted-by":"publisher","first-page":"e2559108","DOI":"10.1001\/jamanetworkopen.2025.59108","volume":"9","author":"JY Chow","year":"2026","unstructured":"Chow, J. Y. et al. Complications, deaths, and disability burden in the 2 years following dengue infection. JAMA Netw. Open 9, e2559108 https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.59108 (2026).","journal-title":"JAMA Netw. Open"},{"key":"744_CR249","doi-asserted-by":"publisher","first-page":"e0012932","DOI":"10.1371\/journal.pntd.0012932","volume":"19","author":"W-X Zhang","year":"2025","unstructured":"Zhang, W.-X. et al. Assessing the global dengue burden: incidence, mortality, and disability trends over three decades. PLoS Negl. Trop. Dis. 19, e0012932 https:\/\/doi.org\/10.1371\/journal.pntd.0012932 (2025).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"744_CR250","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1016\/S1473-3099(25)00500-6","volume":"26","author":"S Yacoub","year":"2026","unstructured":"Yacoub, S. et al. Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE). Lancet Infect. Dis. 26, e231\u2013e244 https:\/\/doi.org\/10.1016\/S1473-3099(25)00500-6 (2026).","journal-title":"Lancet Infect. Dis."},{"key":"744_CR251","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.4161\/hv.24188","volume":"9","author":"SJ Thomas","year":"2013","unstructured":"Thomas, S. J. Dengue human infection model: re-establishing a tool for understanding dengue immunology and advancing vaccine development. Hum. Vaccines Immunother. 9, 1587\u20131590 https:\/\/doi.org\/10.4161\/hv.24188 (2013).","journal-title":"Hum. Vaccines Immunother."},{"key":"744_CR252","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41577-026-01298-y","volume":"26","author":"L Swadling","year":"2026","unstructured":"Swadling, L., Fumagalli, V., Maini, M. K. & Iannacone, M. Abortive infection: T cells as early, antibody-independent defenders. Nat. Rev. Immunol. 26, 327\u2013329 https:\/\/doi.org\/10.1038\/s41577-026-01298-y (2026).","journal-title":"Nat. Rev. Immunol."},{"key":"744_CR253","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41564-024-01903-7","volume":"10","author":"S Kalimuddin","year":"2025","unstructured":"Kalimuddin, S. et al. Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humans. Nat. Microbiol. 10, 374\u2013387 https:\/\/doi.org\/10.1038\/s41564-024-01903-7 (2025).","journal-title":"Nat. Microbiol."},{"key":"744_CR254","unstructured":"European Centre for Disease Prevention and Control. Seasonal Surveillance of Dengue in the EU\/EEA, Weekly Report https:\/\/go.nature.com\/4dIvma2 (ECDC, accessed 15 June 2026)."},{"key":"744_CR255","unstructured":"European Centre for Disease Prevention and Control. Historical Data on Local Transmission of Dengue in the EU\/EEA https:\/\/go.nature.com\/4ho4peg (ECDC, accessed 15 June 2026)."},{"key":"744_CR256","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tim.2025.07.001","volume":"34","author":"E Couderc","year":"2026","unstructured":"Couderc, E., Lambrechts, L. & Merkling, S. H. Decoding mosquito-virus interactions: from classical genetics to multi-omics. Trends Microbiol. 34, 50\u201361 https:\/\/doi.org\/10.1016\/j.tim.2025.07.001 (2026).","journal-title":"Trends Microbiol."},{"key":"744_CR257","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1056\/NEJMoa2503304","volume":"394","author":"JT Lim","year":"2026","unstructured":"Lim, J. T. et al. Dengue suppression by male Wolbachia-infected mosquitoes. N. Engl. J. Med. 394, 1175\u20131183 https:\/\/doi.org\/10.1056\/NEJMoa2503304 (2026).","journal-title":"N. Engl. J. Med."},{"key":"744_CR258","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1056\/NEJMoa2030243","volume":"384","author":"A Utarini","year":"2021","unstructured":"Utarini, A. et al. Efficacy of Wolbachia-infected mosquito deployments for the control of dengue. N. Engl. J. Med. 384, 2177\u20132186 https:\/\/doi.org\/10.1056\/NEJMoa2030243 (2021).","journal-title":"N. Engl. J. Med."},{"key":"744_CR259","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.cell.2009.11.042","volume":"139","author":"LA Moreira","year":"2009","unstructured":"Moreira, L. A. et al. A Wolbachia symbiont in Aedes aegypti limits infection with dengue, chikungunya, and Plasmodium. Cell 139, 1268\u20131278 https:\/\/doi.org\/10.1016\/j.cell.2009.11.042 (2009).","journal-title":"Cell"},{"key":"744_CR260","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S1473-3099(22)00436-4","volume":"22","author":"G Ribeiro Dos Santos","year":"2022","unstructured":"Ribeiro Dos Santos, G. et al. Estimating the effect of the wMel release programme on the incidence of dengue and chikungunya in Rio de Janeiro, Brazil: a spatiotemporal modelling study. Lancet Infect. Dis. 22, 1587\u20131121 https:\/\/doi.org\/10.1016\/S1473-3099(22)00436-4 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"744_CR261","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3201\/eid1206.051210","volume":"12","author":"EE Ooi","year":"2006","unstructured":"Ooi, E. E., Goh, K.-T. & Gubler, D. J. Dengue prevention and 35 years of vector control in Singapore. Emerg. Infect. Dis. 12, 887\u2013893 https:\/\/doi.org\/10.3201\/eid1206.051210 (2006).","journal-title":"Emerg. Infect. Dis."},{"key":"744_CR262","doi-asserted-by":"publisher","first-page":"e0011400","DOI":"10.1371\/journal.pntd.0011400","volume":"17","author":"SH Ho","year":"2023","unstructured":"Ho, S. H. et al. Singapore\u2019s 5 decades of dengue prevention and control\u2014implications for global dengue control. PLoS Negl. Trop. Dis. 17, e0011400 https:\/\/doi.org\/10.1371\/journal.pntd.0011400 (2023).","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00744-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:32:46Z","timestamp":1792085566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00744-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":262,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["744"],"URL":"https:\/\/doi.org\/10.1038\/s41572-026-00744-4","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"11 September 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The following have served in advisory capacities on dengue for companies developing dengue vaccines and therapeutics: E.L.-M., S.K., S.J.T. and E.E.O. for Sanofi Pasteur and Takeda Pharmaceuticals; S.K., S.J.T., S.Y. and E.E.O. for Johnson & Johnson; S.J.T. and E.E.O. for MSD (Merck) and Island Pharmaceuticals; S.J.T. for Meiji, Primevax, Tremeau and Chugai; and S.Y. and E.E.O. for Novartis. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"68"}}